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Propofol and Aminophylline Antagonize Each Other During the 
Mobilization of Intracellular Calcium in Human Umbilical Vein 
Endothelial Cells
This study examined whether propofol and aminophylline affect the mobilization of 
intracellular calcium in human umbilical vein endothelial cells. Intracellular calcium was 
measured using laser scanning confocal microscopy. Cultured and serum-starved cells on 
round coverslips were incubated with propofol or aminophylline for 30 min, and then 
stimulated with lysophosphatidic acid, propofol and aminophylline. The results were 
expressed as relative fluorescence intensity and fold stimulation. Propofol decreased the 
concentration of intracellular calcium, whereas aminophylline caused increased 
mobilization of intracellular calcium in a concentration-dependent manner. Propofol 
suppressed the lysophosphatidic acid-induced mobilization of intracellular calcium in a 
concentration-dependent manner. Propofol further prevented the aminophylline-induced 
increase of intracellular calcium at clinically relevant concentrations. However, 
aminophylline reversed the inhibitory effect of propofol on the elevation of intracellular 
calcium by lysophosphatidic acid. Our results suggest that propofol and aminophylline 
antagonize each other on the mobilization of intracellular calcium in human umbilical vein 
endothelial cells at clinically relevant concentrations. Serious consideration should be given 
to how this interaction affects mobilization of intracellular calcium when these two drugs 
are used together.
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INTRODUCTION
Propofol is a widely used, intravenous, general anesthetic that 
provides long-term sedation of patients in intensive-care units, 
with effects on the central nervous and cardiovascular systems 
as a modulator of intracellular calcium mobilization (1-3). Pro-
pofol suppresses the mobilization of intracellular calcium in my-
ocytes, astrocytoma cells, pituitary cells, and endothelial cells 
(2-6). 
  We examined whether propofol affects the mobilization of 
intracellular calcium in human umbilical vein endothelial cells 
(HUVECs). Furthermore, we examined whether propofol gave 
influences on the mobilization of intracellular calcium by lyso-
phosphatidic acid (LPA), which stimulates intracellular calcium 
mobilization (7, 8). We also tested whether other commonly used 
drugs in intensive-care units stimulated the mobilization of in-
tracellular calcium. Aminophylline, a bronchodilator for asth-
matics, stimulated the mobilization of intracellular calcium in 
HUVECs (9, 10). However, the interaction of propofol and ami-
nophylline, which affects the mobilization of intracellular calci-
um, has never been studied in vitro. Therefore, we studied wheth-
er propofol and aminophylline affect the mobilization of intra-
cellular calcium in HUVECs.
 
MATERIALS AND METHODS
Chemicals and reagents
Fetal bovine serum, bovine serum albumin, penicillin/strepto-
mycin solution, and M199 medium were obtained from Gibco-
BRL (Gaithersburg, MD, USA). Fluo-4-AM was obtained from 
Molecular Probes (Eugene, OR, USA). Propofol was obtained 
from Jeil Pharmaceutical Co. (Seoul, Korea). Aminophylline was 
obtained from Daewon Pharmaceutical Co. (Seoul, Korea), and 
LPA was obtained from Sigma (St. Louis, MO, USA).
Cell culture
HUVECs were obtained from Kangwon National University 
Hospital. HUVECs were prepared from human umbilical veins, 
which were aseptically removed from the placenta immediately 
after birth. HUVECs were isolated using a modified method by 
which the umbilical vein was washed with phosphate buffered 
saline (PBS) solution, followed by treatment with collagenase http://jkms.org   1223 DOI: 10.3346/jkms.2010.25.8.1222
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for 10 min at 37°C. The perfusate was centrifuged at 1,000 r.p.m. 
for 10 min and the resulting cells were cultured on 0.2% gelatin-
coated dishes in M199 medium supplemented with 10% heat-
inactivated fetal bovine serum, 5% heat-inactivated human se-
rum, 100 U/mL penicillin, 100 µg/mL streptomycin, 90 µg/mL 
heparin, and 20 µg/mL endothelial cell growth factor (ECGF), 
at 37°C in a 5% CO2 humid incubator until 80% confluent. Only 
adherent confluent cells originating from the same umbilical 
cord were used in each experimental group. Passages three to 
four were used for all experiments. The cells were analyzed in 
six multi-well plates (the area of each well was 9.6 cm
2), with a 
mean value of 100,000 cells/cm
2. Endothelial cells were identi-
fied by their typical morphological pattern (cobblestone mor-
phology), the presence of monolayers, and positive detection of 
von Willebrand factor. The quality of the monolayer was moni-
tored by inverted microscopy (Diaphot 100; Nikon, Tokyo, Japan). 
Cells were starved for 6 hr in M199 medium supplemented with 
1% heated-inactivated fetal bovine serum, 100 U/mL penicillin, 
100 µg/mL streptomycin, 90 µg/mL heparin and 20 µg/mL ECGF 
(starvation-medium) prior to any pharmacological treatment. 
 
Measurement of intracellular Ca
2+
Changes in [Ca
2+]i were monitored by laser scanning confocal 
microscopy, as described by Lee et al. (11). Briefly, cells were 
grown on round coverslips in multi-well culture plates, serum-
starved for 6 hr and then incubated with 2 μM of Fluo-4-AM in 
starvation medium for 40 min. Round coverslips containing the 
stained cells were mounted on a perfusion chamber (MPS-1000, 
Seoul Engineering, Seoul, Korea) and examined by laser scan-
ning confocal microscopy (Carl Zeiss LSM 410, Heidenheim, 
Germany). After this, coverslips were scanned with a 488 nm 
excitation argon laser and observed through a 515 nm longpass 
emission filter. 
  In addition, cells were incubated with propofol (0; 10; 30; 100; 
300; 1,000 μM) for 30 min, followed by stimulation with LPA (0; 
5 μg/mL) and aminophylline (0; 30; 100; 300; 1,000 μM) to mea-
sure the effects of propofol against stimulation-induced changes 
in [Ca
2+]i. Cells were also incubated with the indicated concen-
trations of propofol (0; 10; 30 μM) and aminophylline (0; 100; 
1,000 μM) for 30 min, followed by stimulation with LPA (0; 5 μg/
mL) and aminophylline (0; 100; 1,000 μM) to measure the inter-
action of propofol and aminophylline on the mobilization of 
[Ca
2+]i. 
  Confirmation of intracellular calcium by illumination was 
demonstrated by the appearance of ‘hot spots’ in both the cyto-
plasmic and nuclear regions following the addition of LPA, pro-
pofol, or aminophylline. The increased density of hot spots was 
analyzed by automated recording of the same region of a cell and 
then plotted with time. The average density of hot spots within 
a cell was an average of 10 areas. Continuous recordings of the 
cell were made by the automatic photography system by scan-
ning every 10 sec. The results are expressed as relative fluores-
cence intensity (RFI) for changes of [Ca
2+]i at the single cell level 
and expressed as fold stimulation (mean±SD) determined by 
comparing RFIs before stimulation from three separate deter-
minations. Each determination represents the mean of at least 
10 cells. 
Data analysis
The data are presented as the mean±standard deviation (SD). 
Data were analyzed by performing repeated measurements of 
one-way analysis of variance (ANOVA) for the serial compari-
sons before and after stimulation by LPA, propofol, or amino-
phylline within the cell and ANOVA between the cells, followed 
by the Scheffe test. In all comparisons, a P value less than 0.05 
was considered statistically significant. The statistical analyses 
were performed using the SPSS program (version 12.0; SPSS 
Inc., Chicago, IL, USA). 
 
RESULTS
The fluorescence intensity in untreated HUVECs loaded with 
Fluo-4 was very low and distributed homogeneously through-
out the cells (Fig. 1A). Fluo-4 fluorescence in cells treated with 5 
μg/mL of LPA or 1,000 μM of aminophylline increased rapidly 
(Fig. 1C, D). Propofol (300 μM) blocked the increase induced by 
Fig. 1. Fluorescence of intracellular calcium in human umbilical-vein endothelial cells (HUVECs) incubated with Fluo-4 and detected by a fluorescence spectrophotometer (confocal 
microscope). (A) Control group (resting cells) before treatment. (B) Preincubation with propofol (300 µM) blocks lysophosphatidic acid (LPA) signals. (C) Aminophylline (1,000 
µM) treatment increases Fluo-4 fluorescence. (D) LPA (5 µg/mL) increases Fluo-4 fluorescence.
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LPA (5 μg/mL) (Fig. 1B). HUVECs treated with LPA (5 μg/mL) 
showed a very rapid increase in [Ca
2+]i (Fig. 2A), but propofol 
blocked this increase dose-dependently at clinically relevant 
concentrations (10, 30 μM) (Fig. 2B). 
  Aminophylline induced a very rapid, dose-dependent increase 
in [Ca
2+]i (Fig. 3), and propofol (300 μM) treatment decreased 
the concentration of [Ca
2+]i. Aminophylline (1,000 μM) rapidly 
increased Fluo-4 fluorescence in cells to a maximum three to 
four-fold higher than the control (Fig. 3). Propofol (10 μM) treat-
ment for 30 min decreased [Ca
2+]i induced by LPA (5 μg/mL) 
and aminophylline (100 μM) (Fig. 4A). Propofol (30 μM) showed 
similar activity (Fig. 4B).  Following incubation with propofol 
(30 μM) and aminophylline (100; 1,000 μM) for 30 min, the peak 
level of [Ca
2+]i following LPA (5 μg/mL) treatment was higher 
than propofol (30 μM) only (Fig. 5). Furthermore, HUVECs in-
cubated with propofol (30 μM) and aminophylline (1,000 μM) 
for 30 min had peak [Ca
2+]i levels higher than propofol (30 μM) 
and aminophylline (100 μM) (Fig. 5). 
 
DISCUSSION
In this study, propofol decreased the concentration of [Ca
2+]i in 
HUVECs, whereas aminophylline (30-1,000 μM) increased mo-
bilization of [Ca
2+]i in a concentration-dependent manner. Pro-
pofol (10-1,000 μM) suppressed the LPA-induced mobilization 
of [Ca
2+]i in a concentration-dependent manner. Propofol fur-
ther prevented the aminophylline-induced increase of [Ca
2+]i at 
clinically relevant concentrations (10 and 30 μM). However, ami-
nophylline reversed the inhibitory effect of propofol on the ele-
vation of [Ca
2+]i by LPA. 
  Cells employ various mechanisms for regulating the concen-
tration of free Ca
2+ in the cytosol, which usually is maintained 
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Fig. 2. Propofol inhibits lysophosphatidic acid (LPA)-induced intracellular calcium ([Ca
2+]i) elevation. (A) Levels of [Ca
2+]i generated by propofol. Cells preincubated in propofol for 
30 min and treated with LPA (5 µg/mL). Serum-starved HUVECs were loaded with 2 µM of Fluo-4 for 40 min. Results are expressed as relative fluorescence intensity (RFI). 
Each trace is of a single cell and is representative of at least three independent experiments. Intracellular Ca
2+ was monitored by confocal microscopy. P10 µM→LPA (S): 
incubation with propofol (10 µM) for 30 min and then treatment with LPA (5 µg/mL); P30 µM→LPA (S): incubation with propofol (30 µM) for 30 min and then treatment with 
LPA (5 µg/mL); P100 µM→LPA (S): incubation with propofol (100 µM) for 30 min and then treatment with LPA (5 µg/mL); P1,000 µM→LPA (S): incubation with propofol (1,000 
µM) for 30 min and then treatment with LPA (5 µg/mL). (B) Propofol inhibits LPA-induced [Ca
2+]i elevation in a dose-dependent manner. Values represent the mean peak 
intracellular calcium response. Results are expressed as fold-stimulation, determined by comparing RFIs before stimulation and expressed as mean±SD from three separate 
determinations. Each determination represents the mean of at least 10 cells.
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Fig. 3. Representative trace of intracellular calcium ([Ca
2+]i) induced by drugs. (A) The elevation of [Ca
2+]i generated by aminophylline treatment in HUVECs. Serum-starved 
HUVECs were loaded with 2 µM of Fluo-4 for 40 min. Results are expressed as relative fluorescence intensity (RFI). Each trace is of a single cell and is representative of at least 
three independent experiments. Intracellular Ca
2+ was monitored by confocal microscopy. A, aminophylline; P, propofol; LPA, lysophosphatidic acid; (s), treatment. (B) Levels of 
mean peak [Ca
2+]i generated by various concentrations of aminophylline in HUVECs. Aminophylline generates [Ca
2+]i elevation in a dose-dependent manner. Values represent 
the mean peak intracellular calcium response. Results are expressed as fold-stimulation, determined by comparing RFIs before stimulation and expressed as mean±SD from 
three separate determinations. Each determination represents the mean of at least 10 cells.
A B
Control
A1,000 µM (S)
A100 µM (S)
LPA 5 µg/mL (S)
P300 µM (S)http://jkms.org   1225 DOI: 10.3346/jkms.2010.25.8.1222
Son H-J, et al.  •  Propofol and Aminophylline Antagonize [Ca
2+]i Mobilization  
below 0.2 μM. Therefore, most investigators measure the effect 
of a substance on the increase and/or decrease of [Ca
2+]i medi-
ated by that specific substance, rather than directly measuring 
[Ca
2+]i (5). In this study, we determined changes of [Ca
2+]i that 
occurred in response to LPA.
  LPA has multiple cellular effects, including the stimulation of 
phospholipases, the mobilization of [Ca
2+]i, and the inhibition of 
adenylate cyclase (12). The extracellular addition of LPA increased 
[Ca
2+]i through mobilization of intracellular calcium stores as 
well as through the influx of extracellular Ca
2+ (6). However, the 
ability of LPA to stimulate increases in [Ca
2+]i is mediated pre-
dominantly via the mobilization of calcium stores (13). This ac-
tion is transduced by the production of inositol triphosphate 
(IP3) through the G-protein-mediated activation of phospholi-
pase C (12). In this study, propofol decreased the concentration 
of [Ca
2+]i in HUVECs as in other cells (2-6). Also, propofol sup-
pressed the increase of [Ca
2+]i by LPA in a concentration-depen-
dent manner. 
  Propofol is a brief-acting, intravenous, anesthetic agent pos-
sessing significant cardiovascular effects (14). Systemic hypo-
tension caused by a marked decrease in systemic vascular resis-
tance is often observed in the clinical use of propofol, probably 
via a decrease in [Ca
2+]i. The negative inotropic and vasodilatory 
effects associated with propofol are likely due the voltage-gated 
influx of extracellular calcium being blocked, and to the decrease 
in availability of intracellular calcium (1, 4). Propofol affects [Ca
2+]i 
by inhibiting the mobilization of intracellular-calcium stores (6). 
It also blocks the voltage-gated influx of extracellular Ca
2+ by act-
ing as a calcium channel blocker (6). In endothelial cells, the 
activation of adenosine-triphosphate-sensitive potassium chan-
nels (K
+ATP channels) is dependent upon L-type, voltage-gated 
calcium channels, and causes an increase in K
+ efflux, mem-
brane hyperpolarization and calcium influx (15). Propofol at-
tenuates the effect of K
+ATP channels by inhibiting the nitric 
oxide pathway (16). The mobilization of calcium from intracel-
lular stores is related to the hydrolysis of inositol-4,5-biphos-
phate (PIP2) to diacylglycerol and IP3 (17). IP3 releases internal 
calcium in endothelial cells, therefore triggering the calcium 
cascade and its associated biological process, such as vasocon-
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Fig. 4. Levels of mean peak intracellular calcium ([Ca
2+]i) generated by lysophosphatidic acid (LPA) or aminophylline treatment after incubation with propofol (10, 30 µM) for 30 
min. (A) Levels of mean peak intracellular calcium ([Ca
2+]i) generated by lysophosphatidic acid (LPA) or aminophylline treatment after incubation with propofol (10 µM) and for 
30 min. LPA only: treatment with LPA (5 µg/mL); P10→LPA: incubation with propofol (10 µM) and treatment with LPA (5 µg/mLl); A100 only: treatment with aminophylline (100 
µM); P10→A100: incubation with propofol (10 µM) and treatment with aminophylline (100 µM) Values represent the mean peak intracellular calcium response. Results are 
expressed as fold-stimulation, determined by comparing relative fluorescence intensities (RFI) before stimulation and expressed as mean±SD from three separate determinations. 
Each determination represents the mean of at least 10 cells. (B) Levels of mean peak intracellular calcium ([Ca
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mean peak intracellular calcium response. Results are expressed as fold-stimulation, determined by comparing relative fluorescence intensities (RFI) before stimulation and 
expressed as mean±SD from three separate determinations. Each determination represents the mean of at least 10 cells.
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striction (18). Propofol reduces the production of IP3 and can 
thus act as a calcium blocker preventing the entry of calcium 
into the vasodilatation pathway (18). It further inhibits the entry 
of capacitative calcium and modulates Na
+-Ca
2+ exchange activ-
ity via the protein kinase C-signaling pathway (19, 20). The acti-
vation of protein kinase C by phorbol esters can be inhibited by 
propofol (20). In the present study, propofol suppressed the LPA-
induced mobilization of [Ca
2+]i  in HUVECs in a dose-dependent 
manner, presumably via one of these mechanisms.
  Aminophylline is a bronchodilating drug widely used for the 
treatment of asthma and chronic airway-obstructing diseases 
(21). Aminophylline exerts multiple pharmacological effects ei-
ther through phosphodiesterase inhibition or via adenosine re-
ceptor blockage (22, 23). It furthermore activates cyclic adenos-
ine monophosphate (cAMP) and cyclic guanosine monophos-
phate (cGMP) (24) and enhances calcium currents. Adenosine 
inhibits calcium channels through a pertussis-toxin-sensitive G 
protein (24). In the present study, aminophylline increased in-
tracellular calcium in a concentration-dependent manner in 
HUVECs. Specifically, aminophylline probably enhanced calci-
um release from the sarcoplasmic reticulum, along with the in-
flux of extracellular calcium. 
  In the present study, there are two possible cellular mecha-
nisms of the opposing effects of propofol and aminophylline on 
intracellular calcium mobilization. First, propofol blocks the volt-
age-gated influx of extracellular Ca
2+ by acting as a calcium chan-
nel blocker (6), but aminophylline induced an influx of Ca
2+ by 
activating calcium channels (23, 24). Second, propofol reduces 
the production of IP3 and calcium release from intracellular stores 
(16, 17), but aminophylline induced Ca
2+ release from intracel-
lular stores, occurs via increased production of IP3 through G-
protein-mediated activation (21, 25).
  Aminophylline has a narrow therapeutic index (9), with side 
effects of nausea, headache, and diuresis. The misuse or abuse 
of aminophylline can cause life-threatening cardiovascular con-
ditions, such as cardiac arrhythmias and seizures (9, 10). Over-
doses of aminophylline are the most common cause of death 
due to hospital-related asthma (10). Serious toxicity has been 
reported when high, prolonged doses of aminophylline are ad-
ministered through continuous intravenous infusion (26). Ami-
nophylline changes intracellular calcium concentrations (27), 
and calcium plays a major role in aminophylline-induced tox-
icity and death (28). 
  Propofol is widely used in intensive care medicine, especially 
for the long-term sedation of critically ill patients (29). Side ef-
fects, such as hypotension, vasodilation, and propofol infusion 
syndrome, are possible when used clinically. These side effects 
act as calcium channel blockers that cause cardiovascular de-
pression (1). Aminophylline reverses propofol-induced postop-
erative sedation (22). 
  In this study, propofol and aminophylline showed opposing 
effects on intracellular calcium mobilization in HUVECs. Al-
though this may decrease drug-related side effects, it may also 
decrease therapeutic effects. Therefore, clinicians should give 
adequate doses when administered together. Further work is 
required to understand the mechanism of interaction of propo-
fol and aminophylline on intracellular calcium mobilization in 
HUVECs and its effects in the other cells such as bronchial and 
neuronal cells.
  In conclusion, propofol and aminophylline antagonize [Ca
2+]i 
mobilization at clinically relevant concentrations in HUVECs. 
Serious consideration shou ld be given to drug interactions on 
intracellular calcium mobilization when used together.
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